Dr. Gill explains the importance of BPH treatment innovations to urology

Video

“It’s pretty clear that over the past 50 years we've seen innovations in BPH treatment both from the utilization of technology and also from the patient outcome and experience standpoint,” says Bradley Gill, MD, MS.

Urology Times® is celebrating its 50th anniversary in 2022. To mark the occasion, we are highlighting 50 of the top innovations and developments that have transformed the field of urology over the past 50 years. In this installment, Bradley Gill, MD, MS discusses the importance of the new wave of minimally invasive BPH treatments for both patients and clinicians. Gill is a urologist with Glickman Urological & Kidney Institute at Cleveland Clinic.

Related Videos
Dr. McVary in an interview with Urology Times
A panel of 4 experts on bladder cancer seated at a long table
A panel of 5 experts on bladder cancer
A panel of 5 experts on bladder cancer
A panel of 4 experts on bladder cancer seated at a long table
A panel of 4 experts on bladder cancer seated at a long table
A panel of 4 experts on bladder cancer seated at a long table
A panel of 4 experts on bladder cancer seated at a long table
A panel of 4 experts on bladder cancer seated at a long table
Related Content
A new standard emerges in advanced urothelial carcinoma after decades of first-line chemotherapy

A new standard emerges in advanced urothelial carcinoma after decades of first-line chemotherapy

January 4th 2024
Article

Data from the EV-302 trial showed a doubling of progression-free survival and overall survival with the ADC/checkpoint combination versus standard chemotherapy.

Dr. Schwen on focal therapies for prostate cancer

Dr. Schwen on focal therapies for prostate cancer

January 11th 2024
Podcast

Zeyad Schwen, MD, a urologic oncologist at Cleveland Clinic, discusses how patient factors and cancer characteristics are key to deciding between focal therapies and whole gland treatment for prostate cancer.

Cleveland Clinic trial compares shockwave vs radial wave therapy for ED in prostate cancer survivors

Cleveland Clinic trial compares shockwave vs radial wave therapy for ED in prostate cancer survivors

December 14th 2023
Article

Novel research to evaluate noninvasive treatments in erectile dysfunction and chronic pelvic pain

male patient sitting in clinic room while doctor talks with him

Dr. Gange discusses data on the UroLift System for BPH

May 23rd 2023
Podcast

The data were presented at the recent American Urological Association Annual Meeting.

Michigan Institute of Urology opens dedicated outpatient medical center for minimally invasive health care

Michigan Institute of Urology opens dedicated outpatient medical center for minimally invasive health care

December 13th 2023
Article

The center will offer a comprehensive range of treatments, including prostate artery embolization for men suffering from benign prostatic hyperplasia with very large prostates.

Germline biomarker offers insight into treatment selection for men with prostate cancer

Germline biomarker offers insight into treatment selection for men with prostate cancer

December 11th 2023
Article

Correlation found between the biomarker HSD3B1 and resistance to combined hormone therapy and radiotherapy

© 2024 MJH Life Sciences

All rights reserved.